The Noida based BACFO Pharmaceutical India Ltd is expanding its domestic as well international operations. The company will be entering into Qatar, UAE and other West Asian markets in three months time.

BACFO is a manufacturer of research-based Ayurvedic (Herbal) pharmaceuticals and herbal supplements. Through its extensive R&D strength in traditional remedies, it has developed 16 products for arthritis, spondilytis and joint pains, hyperacidity and indigestion, constipation, weight loss and fat loss, restore sluggish liver functions, liver tonic, hypertension, piles and fistula, diabetes and blood sugar reducer, respiratory allergies, hair loss, stress and brain tonic, immune booster, cholesterols control, and menstrual relief.

Speaking to Pharmabiz, Rajesh Puri, vice president, BACFO, said, "We are working on our domestic as well as international expansion. We will be hiring around 80 people for our overall expansion. The company has completed registration process in Latin America, Guatemala and for UAE. We are in process to register for Qatar and are expecting to get it done shortly".

The company has its international presence at USA, UK and Middle East. In Middle East it is already present in Yemen and Kuwait. Whereas, it's domestic operations are mainly in North East, Kerala, Gujarat and Assam. The company is planning to make its strong presence at Tamil Nadu, Karnataka, Maharashtra and Madhya Pradesh in another three months. It will be exploring its business outreach through its existing product range.